Evaluation of the analytical sensitivity of ACON and LumiraDx SARS-CoV-2 rapid antigen tests using samples with presumed Omicron variant
暂无分享,去创建一个
L. Donato | A. Moyer | B. Karon | Amy M. Wockenfus | R. Majumdar | B. Kipp | Brandon R. Kelley | J. Yao
[1] M. Batty,et al. Analytical Sensitivity of Lateral Flow Devices against SARS-CoV-2 Omicron Subvariants BA.4, BA.5, and BA.2.75 , 2022, Journal of clinical microbiology.
[2] I. Eckerle,et al. Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant , 2022, Microbiology spectrum.
[3] A. Baiker,et al. Analysis of seven SARS-CoV-2 rapid antigen tests in detecting omicron (B.1.1.529) versus delta (B.1.617.2) using cell culture supernatants and clinical specimens , 2022, Infection.
[4] R. Arnaout,et al. Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture , 2022, Journal of clinical microbiology.
[5] J. Dogné,et al. Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant , 2022, Viruses.
[6] L. Kaderali,et al. Impaired detection of omicron by SARS-CoV-2 rapid antigen tests , 2022, Medical Microbiology and Immunology.
[7] H. Yassine,et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines , 2022, Annals of medicine.
[8] R. Schinazi,et al. Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern , 2022, iScience.
[9] M. Kamal,et al. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic , 2022, Environmental Research.
[10] M. Batty,et al. Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant , 2021, Journal of clinical microbiology.
[11] A. Pandey,et al. Analytical sensitivity and specificity of four point of care rapid antigen diagnostic tests for SARS-CoV-2 using real-time quantitative PCR, quantitative droplet digital PCR, and a mass spectrometric antigen assay as comparator methods. , 2021, Clinical chemistry.
[12] J. Ruijter,et al. Efficiency-correction is required for accurate qPCR analysis and reporting. , 2021, Clinical chemistry.
[13] B. Hiestand,et al. Evaluation of Performance of the BD Veritor SARS-CoV-2 Chromatographic Immunoassay Test in Patients with Symptoms of COVID-19 , 2021, Journal of Clinical Microbiology.
[14] P. Drain,et al. A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study , 2021, Infectious Diseases and Therapy.
[15] R. Orlandi,et al. Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting , 2021, Journal of Clinical Microbiology.
[16] J. Tate,et al. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020 , 2021, MMWR. Morbidity and mortality weekly report.
[17] N. Lennon,et al. Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts , 2021, Journal of Clinical Microbiology.
[18] E. Crawford,et al. Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco , 2021, The Journal of infectious diseases.
[19] M. Killerby,et al. Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020 , 2021, MMWR. Morbidity and mortality weekly report.
[20] E. Beck,et al. Comparison of the Quidel Sofia SARS FIA Test to the Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of COVID-19 in Symptomatic Outpatients , 2020, Journal of Clinical Microbiology.
[21] A. Gayet-Ageron,et al. Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers , 2020, medRxiv.
[22] E. Crawford,et al. Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco , 2020, medRxiv.
[23] Gannon C.K. Mak,et al. Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus , 2020, Journal of Clinical Virology.
[24] Charles K. Cooper,et al. Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia SARS Antigen point-of-care test. , 2020, medRxiv.
[25] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.